We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Public Citizen Pushes FDA to Add Boxed Warning to Dopamine Agonist Drugs
Public Citizen Pushes FDA to Add Boxed Warning to Dopamine Agonist Drugs
Public Citizen is calling on the FDA to add a boxed warning to a class of drugs for treating Parkinson’s disease and ADHD to address a potential link to behavioral problems.